BG27537A3 - Method of obtaining of mixed polyolic esters - Google Patents

Method of obtaining of mixed polyolic esters

Info

Publication number
BG27537A3
BG27537A3 BG034871A BG3487176A BG27537A3 BG 27537 A3 BG27537 A3 BG 27537A3 BG 034871 A BG034871 A BG 034871A BG 3487176 A BG3487176 A BG 3487176A BG 27537 A3 BG27537 A3 BG 27537A3
Authority
BG
Bulgaria
Prior art keywords
polyolic
esters
obtaining
mixed
polyolic esters
Prior art date
Application number
BG034871A
Other languages
Bulgarian (bg)
English (en)
Inventor
Pierre Bandet
Jean Ricard
Adrian Schultness
Original Assignee
Неизвестен
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH17376A external-priority patent/CH616911A5/fr
Priority claimed from CH979076A external-priority patent/CH617175A5/fr
Application filed by Неизвестен filed Critical Неизвестен
Publication of BG27537A3 publication Critical patent/BG27537A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00—Esters of sulfuric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Steroid Compounds (AREA)
BG034871A 1976-01-08 1976-12-09 Method of obtaining of mixed polyolic esters BG27537A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH17376A CH616911A5 (pl) 1976-01-08 1976-01-08
CH979076A CH617175A5 (en) 1976-07-30 1976-07-30 Processes for the preparation of mixed polyol esters

Publications (1)

Publication Number Publication Date
BG27537A3 true BG27537A3 (en) 1979-11-12

Family

ID=25683750

Family Applications (1)

Application Number Title Priority Date Filing Date
BG034871A BG27537A3 (en) 1976-01-08 1976-12-09 Method of obtaining of mixed polyolic esters

Country Status (18)

Country Link
JP (1) JPS5285139A (pl)
BG (1) BG27537A3 (pl)
CA (1) CA1075708A (pl)
DD (1) DD128400A5 (pl)
DE (1) DE2654951A1 (pl)
EG (1) EG12290A (pl)
ES (1) ES453795A1 (pl)
FI (1) FI763529A (pl)
FR (1) FR2337552A1 (pl)
GB (1) GB1572035A (pl)
GR (1) GR61818B (pl)
IL (1) IL51039A0 (pl)
NL (1) NL7613457A (pl)
PL (1) PL117246B1 (pl)
PT (1) PT65894B (pl)
RO (1) RO70355A (pl)
SE (1) SE7613426L (pl)
YU (1) YU286476A (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL176551C (nl) * 1979-04-25 1985-05-01 Shell Int Research Werkwijze voor de bereiding van een aromatisch koolwaterstofmengsel door katalytische omzetting van een mengsel van koolmonoxyde en waterstof.

Also Published As

Publication number Publication date
CA1075708A (en) 1980-04-15
YU286476A (en) 1982-08-31
GR61818B (en) 1979-01-22
DE2654951A1 (de) 1977-07-21
IL51039A0 (en) 1977-02-28
PL194851A1 (pl) 1979-05-07
PT65894A (fr) 1976-12-01
GB1572035A (en) 1980-07-23
RO70355A (ro) 1981-08-17
SE7613426L (sv) 1977-07-09
ES453795A1 (es) 1978-01-16
PL117246B1 (en) 1981-07-31
FI763529A (pl) 1977-07-09
NL7613457A (nl) 1977-07-12
FR2337552A1 (fr) 1977-08-05
PT65894B (fr) 1978-05-18
DD128400A5 (de) 1977-11-16
EG12290A (en) 1979-06-30
JPS5285139A (en) 1977-07-15

Similar Documents

Publication Publication Date Title
BG27743A3 (en) Method of obtaining of aminoalkylheterocycles
BG27550A3 (en) Method of obtaining of thiazolinyl- or thiazinyl- benzimidazole esters
BG27734A3 (en) Method of obtaining of m- aryloxybenzaldehydes
BG28988A4 (en) Method of obtaining of 4- halo- dihydropropyrans
BG27754A3 (en) Method of obtaining of 3- halomethylcephems
IL53712A (en) Method for the preparation of esters
GB1557506A (en) Preparation of esters
GR65222B (en) Method for the preparation of new esters
BG28718A4 (en) Method of obtaining of corticoids
GR59194B (en) Preparation method of aryloxy-1 amino-3-propanols-2
JPS5353612A (en) Method of manufacturing oxaric ester
JPS52102212A (en) Method of producing halogenoacetal from ester
BG27755A3 (en) Method of obtaining of 7- alkoxy- 3- chlormethilcephems
JPS52107266A (en) Method of making cone
BG27537A3 (en) Method of obtaining of mixed polyolic esters
GR63097B (en) Preparation process of esters
JPS5358596A (en) Method of making polyallylpolyamines
JPS52121933A (en) Method of embanking
JPS532454A (en) Esters of 55methyll10*111dihydroprostaglandinna1
GR63598B (en) Method of preparation of n-6-chloranicotinoylo-ocmocisteino-thiolactone
JPS5350169A (en) Preparation method of tetrazols
JPS52108937A (en) Method of polybrominating bissphenoxyalkane
JPS5377090A (en) Method of etherizing
BG31289A1 (en) Method for obtaining of esters
JPS537621A (en) Method of manufacturing esters